$CHTH
CNL Healthcare Properties, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021004315 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $75.83M $74.18M $76.20M
YoY Change 7.09% -2.65% -4.99%
Cost Of Revenue $56.45M $52.71M $52.12M
YoY Change 10.51% 1.11% 3.84%
Gross Profit $19.38M $21.48M $24.08M
YoY Change -1.77% -10.79% -26.04%
Gross Profit Margin 25.55% 28.95% 31.6%
Selling, General & Admin $5.944M $5.804M $6.784M
YoY Change -13.69% -14.45% -0.78%
% of Gross Profit 30.68% 27.02% 28.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.83M $12.50M $14.30M
YoY Change 3.14% -12.59% 15.91%
% of Gross Profit 66.22% 58.2% 59.4%
Operating Expenses $18.78M $887.0K $886.0K
YoY Change -2.86% 0.11% -19.23%
Operating Profit $601.0K $3.033M $2.914M
YoY Change 50.63% 4.08% -73.64%
Interest Expense -$3.544M -$5.047M -$5.274M
YoY Change -1121.33% -4.3% -39.8%
% of Operating Profit -589.68% -166.4% -180.99%
Other Income/Expense, Net -$5.047M -$5.274M
YoY Change -4.3%
Pretax Income -$12.73M -$2.014M $2.360M
YoY Change -1806.84% -185.34% -48.91%
Income Tax $8.035M -$1.500M -$400.0K
% Of Pretax Income -16.95%
Net Earnings -$20.80M -$533.0K -$1.738M
YoY Change -3122.67% -69.33% -131.87%
Net Earnings / Revenue -27.43% -0.72% -2.28%
Basic Earnings Per Share
Diluted Earnings Per Share -$119.5K -$3.064K -$9.991K
COMMON SHARES
Basic Shares Outstanding 174.0M 174.0M
Diluted Shares Outstanding 174.0M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.16M $55.55M $69.94M
YoY Change -13.52% -20.57% 84.18%
Cash & Equivalents $53.16M $55.55M $76.77M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $53.16M $55.55M $69.94M
YoY Change -13.52% -20.57% 84.18%
LONG-TERM ASSETS
Property, Plant & Equipment $1.347B $1.364B $1.399B
YoY Change -3.28% -2.52% -1.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $17.49M $18.02M $30.08M
YoY Change -31.52% -40.09% -82.04%
Total Long-Term Assets $1.383B $1.410B $1.458B
YoY Change -4.1% -3.25% -9.95%
TOTAL ASSETS
Total Short-Term Assets $53.16M $55.55M $69.94M
Total Long-Term Assets $1.383B $1.410B $1.458B
Total Assets $1.437B $1.466B $1.528B
YoY Change -4.49% -4.05% -7.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.17M $27.37M $29.13M
YoY Change -6.04% 18.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.58M $28.96M $31.16M
YoY Change 1608.16% -7.05% 16.08%
LONG-TERM LIABILITIES
Long-Term Debt $589.1M $590.1M $610.7M
YoY Change -1.83% -3.37% -14.91%
Other Long-Term Liabilities $6.115M $6.358M $8.200M
YoY Change -25.92% -22.46% -18.59%
Total Long-Term Liabilities $595.2M $596.5M $618.9M
YoY Change -2.16% -3.62% -14.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.58M $28.96M $31.16M
Total Long-Term Liabilities $595.2M $596.5M $618.9M
Total Liabilities $625.8M $625.4M $651.9M
YoY Change -1.39% -4.06% -13.61%
SHAREHOLDERS EQUITY
Retained Earnings $101.9M $122.7M $124.1M
YoY Change -18.34% -1.13% 9.82%
Common Stock $1.519B $1.519B
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $809.0M $838.7M $875.7M
YoY Change
Total Liabilities & Shareholders Equity $1.437B $1.466B $1.528B
YoY Change -4.49% -4.05% -7.8%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$20.80M -$533.0K -$1.738M
YoY Change -3122.67% -69.33% -131.87%
Depreciation, Depletion And Amortization $12.83M $12.50M $14.30M
YoY Change 3.14% -12.59% 15.91%
Cash From Operating Activities $13.45M $8.719M $15.49M
YoY Change -13.9% -43.7% -8.39%
INVESTING ACTIVITIES
Capital Expenditures -$5.854M -$4.384M -$2.013M
YoY Change -9.72% 117.78% -11.09%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $5.023M
YoY Change -100.0% -100.0% 6339.74%
Cash From Investing Activities -$5.854M -$4.384M $3.010M
YoY Change -9.51% -245.65% -237.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.38M -14.01M -91.78M
YoY Change -47.86% -84.74% 187.24%
NET CHANGE
Cash From Operating Activities 13.45M 8.719M 15.49M
Cash From Investing Activities -5.854M -4.384M 3.010M
Cash From Financing Activities -10.38M -14.01M -91.78M
Net Change In Cash -2.787M -9.673M -73.28M
YoY Change -74.1% -86.8% 325.26%
FREE CASH FLOW
Cash From Operating Activities $13.45M $8.719M $15.49M
Capital Expenditures -$5.854M -$4.384M -$2.013M
Free Cash Flow $19.30M $13.10M $17.50M
YoY Change -12.68% -25.12% -8.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2020Q3 chth Disposal Cost
DisposalCost
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 chth Disposal Fees
DisposalFees
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 chth Due To Related Party Financing Coordination Fees
DueToRelatedPartyFinancingCoordinationFees
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 chth Disposal Cost
DisposalCost
CY2021Q3 chth Disposal Fees
DisposalFees
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2020Q3 chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2021Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
chth Financing Coordination Fees
FinancingCoordinationFees
CY2021Q3 chth Disposal Group Liabilities On Assets Held For Sale
DisposalGroupLiabilitiesOnAssetsHeldForSale
CY2020Q4 chth Excess Stock Value
ExcessStockValue
CY2021Q3 chth Other Comprehensive Income Loss Interest Rate Caps Reclassification Adjustment From Aoci For Derecognition After Tax
OtherComprehensiveIncomeLossInterestRateCapsReclassificationAdjustmentFromAociForDerecognitionAfterTax
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001496454
CY2020Q4 chth Due To Related Party Financing Coordination Fees
DueToRelatedPartyFinancingCoordinationFees
CY2021Q3 chth Excess Stock Value
ExcessStockValue
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
chth Disposal Cost
DisposalCost
chth Other Comprehensive Income Loss Interest Rate Caps Reclassification Adjustment From Aoci For Derecognition After Tax
OtherComprehensiveIncomeLossInterestRateCapsReclassificationAdjustmentFromAociForDerecognitionAfterTax
dei Amendment Flag
AmendmentFlag
false
CY2020Q3 chth Financing Coordination Fees
FinancingCoordinationFees
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54685
dei Entity Registrant Name
EntityRegistrantName
CNL Healthcare Properties, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2876363
dei Entity Address Address Line1
EntityAddressAddressLine1
CNL Center at City Commons
dei Entity Address Address Line2
EntityAddressAddressLine2
450 South Orange Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
650-1000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
173960540
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1363898000
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1392860000
CY2020Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
7421000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55554000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61475000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4914000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4536000
CY2021Q3 us-gaap Other Assets
OtherAssets
28385000
CY2020Q4 us-gaap Other Assets
OtherAssets
23341000
CY2021Q3 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
13105000
CY2020Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
14408000
CY2021Q3 us-gaap Assets
Assets
1465856000
CY2020Q4 us-gaap Assets
Assets
1504041000
CY2021Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
328593000
CY2020Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
336685000
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
261536000
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
263423000
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
27371000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
24519000
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
6358000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
8255000
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1587000
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1780000
CY2020Q4 chth Disposal Group Liabilities On Assets Held For Sale
DisposalGroupLiabilitiesOnAssetsHeldForSale
10000
CY2021Q3 us-gaap Liabilities
Liabilities
625445000
CY2020Q4 us-gaap Liabilities
Liabilities
634672000
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
502000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
572000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2020Q4 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2020Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2021Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2020Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2021Q3 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2020Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1740000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1740000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
122657000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
124743000
CY2021Q3 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
802586000
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
775866000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
838722000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
867508000
CY2021Q3 us-gaap Minority Interest
MinorityInterest
1187000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1289000
CY2021Q3 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
840411000
CY2020Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
869369000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1465856000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1504041000
CY2021Q3 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
7737000
CY2020Q3 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
6844000
chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
22472000
chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
21779000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17927000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2014000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2360000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5949000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3409000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66446000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69356000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197123000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
214555000
CY2021Q3 us-gaap Revenues
Revenues
74183000
CY2020Q3 us-gaap Revenues
Revenues
76200000
us-gaap Revenues
Revenues
219595000
us-gaap Revenues
Revenues
236334000
CY2021Q3 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
49475000
CY2020Q3 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
48365000
us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
144674000
us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
145496000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2229000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2296000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6747000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7014000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12641000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14378000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37585000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
39376000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
71150000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
73286000
us-gaap Costs And Expenses
CostsAndExpenses
210583000
us-gaap Costs And Expenses
CostsAndExpenses
216072000
CY2021Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0
CY2020Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1074000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3033000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2914000
us-gaap Operating Income Loss
OperatingIncomeLoss
9012000
us-gaap Operating Income Loss
OperatingIncomeLoss
21336000
CY2021Q3 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
25000
CY2020Q3 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
181000
chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
415000
chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
306000
CY2021Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
5248000
CY2020Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
5655000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
15789000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
18839000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
176000
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
200000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
413000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
606000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5047000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5274000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14961000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1502000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-420000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3861000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
905000
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
512000
CY2020Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1940000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2088000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2504000
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
218000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-10000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
798000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-512000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-1722000
us-gaap Profit Loss
ProfitLoss
-2098000
us-gaap Profit Loss
ProfitLoss
3302000
CY2021Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
21000
CY2020Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
16000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-12000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
78000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-533000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1738000
us-gaap Net Income Loss
NetIncomeLoss
-2086000
us-gaap Net Income Loss
NetIncomeLoss
3224000
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.00
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.01
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.02
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-512000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-1722000
us-gaap Profit Loss
ProfitLoss
-2098000
us-gaap Profit Loss
ProfitLoss
3302000
CY2021Q3 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
9000
CY2020Q3 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
-13000
chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
15000
chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
-4000
CY2020Q3 chth Other Comprehensive Income Loss Interest Rate Caps Reclassification Adjustment From Aoci For Derecognition After Tax
OtherComprehensiveIncomeLossInterestRateCapsReclassificationAdjustmentFromAociForDerecognitionAfterTax
2000
chth Other Comprehensive Income Loss Interest Rate Caps Reclassification Adjustment From Aoci For Derecognition After Tax
OtherComprehensiveIncomeLossInterestRateCapsReclassificationAdjustmentFromAociForDerecognitionAfterTax
2000
CY2021Q3 chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
1000
chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
5000
chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
-14000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-502000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1733000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2078000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3286000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
21000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
16000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-12000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
78000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-523000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1749000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2066000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3208000
CY2021Q2 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
849843000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-512000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10000
CY2021Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
23000
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05120
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8907000
CY2021Q3 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
840411000
CY2020Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
869369000
us-gaap Profit Loss
ProfitLoss
-2098000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
160000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1536
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
26720000
CY2021Q3 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
840411000
CY2020Q2 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
888227000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-1722000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11000
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10000
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05120
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8907000
CY2020Q3 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
877577000
CY2019Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
901031000
us-gaap Profit Loss
ProfitLoss
3302000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
95000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1536
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
26720000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
75000
CY2020Q3 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
877577000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
32919000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
46627000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-7000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
870000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32912000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47497000
chth Proceeds From Sale Of Real Estate Discontinued Operations
ProceedsFromSaleOfRealEstateDiscontinuedOperations
0
chth Proceeds From Sale Of Real Estate Discontinued Operations
ProceedsFromSaleOfRealEstateDiscontinuedOperations
53712000
chth Payments For Capital Expenditure Discontinued Operations
PaymentsForCapitalExpenditureDiscontinuedOperations
8332000
chth Payments For Capital Expenditure Discontinued Operations
PaymentsForCapitalExpenditureDiscontinuedOperations
5747000
chth Payments For Proceeds From Other Investing Activities Discontinued Operations
PaymentsForProceedsFromOtherInvestingActivitiesDiscontinuedOperations
-35000
chth Payments For Proceeds From Other Investing Activities Discontinued Operations
PaymentsForProceedsFromOtherInvestingActivitiesDiscontinuedOperations
-26000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-8297000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
47991000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
7402000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
28398000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-895000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
76389000
us-gaap Payments Of Dividends
PaymentsOfDividends
26720000
us-gaap Payments Of Dividends
PaymentsOfDividends
26720000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
40000000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
2242000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
46000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8439000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
28961000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
80000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-159000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
76000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37560000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95651000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5543000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28235000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66011000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48537000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60468000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
76772000
CY2018Q4 chth Number Of Properties
NumberOfProperties
70
CY2018Q4 chth Number Of Properties Sold
NumberOfPropertiesSold
63
CY2018Q4 chth Number Of Skilled Nursing Facilities Held For Sale
NumberOfSkilledNursingFacilitiesHeldForSale
7
CY2019 chth Number Of Properties Sold
NumberOfPropertiesSold
61
CY2020 chth Number Of Properties Sold
NumberOfPropertiesSold
7
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69400000
CY2021Q3 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2020Q3 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
us-gaap Use Of Estimates
UseOfEstimates
<p id="xbrl_ts_699aa1c389e94ae99ac3ba1db7db33aa" style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> —</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor. Accordingly, actual results could differ from those estimates.</span></p>
CY2021Q3 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6107
CY2020Q3 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6107
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66400000
chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6107
chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6107
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197100000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
214600000
chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2021Q3 us-gaap Land And Land Improvements
LandAndLandImprovements
132920000
CY2020Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
132663000
CY2021Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1505299000
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1501107000
CY2021Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
97963000
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
94141000
CY2021Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
372284000
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
335051000
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1363898000
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1392860000
CY2021Q3 us-gaap Depreciation
Depreciation
12500000
us-gaap Depreciation
Depreciation
37300000
CY2020Q3 us-gaap Depreciation
Depreciation
14300000
us-gaap Depreciation
Depreciation
39100000
CY2019 chth Number Of Properties Held For Sale
NumberOfPropertiesHeldForSale
61
CY2019 chth Number Of Other Properties
NumberOfOtherProperties
8
chth Number Of Properties Sold
NumberOfPropertiesSold
6
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1100000
chth Number Of Post Acute Care Properties
NumberOfPostAcuteCareProperties
1
CY2020 chth Number Of Acute Care Properties
NumberOfAcuteCareProperties
1
CY2021Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
CY2020Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
256000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
6000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1112000
CY2021Q3 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
0
CY2020Q3 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
38000
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
19000
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
314000
CY2021Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2020Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
218000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-13000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
798000
CY2021Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2020Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-3000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
218000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-10000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
798000
CY2021Q3 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
12100000
CY2021Q3 chth Liquidity
Liquidity
139300000
us-gaap Debt Instrument Restrictive Covenants
DebtInstrumentRestrictiveCovenants
The credit facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage, (viii) maximum unsecured indebtedness ratio, and (ix) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the credit facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the credit facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of September 30, 2021, the Company was in compliance with all financial covenants related to its Credit Facilities.
chth Financial Covenant Limitations Maximum Allowable Distributions As Percentage Of Adjusted Funds From Operations
FinancialCovenantLimitationsMaximumAllowableDistributionsAsPercentageOfAdjustedFundsFromOperations
0.95
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
887000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
886000
us-gaap Operating Expenses
OperatingExpenses
2360000
us-gaap Operating Expenses
OperatingExpenses
2616000
CY2021Q3 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
396000
CY2020Q4 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
275000
CY2021Q3 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
887000
CY2020Q3 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
886000
chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
12165000
chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
13677000
CY2021Q3 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1191000
chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
2360000
chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
2616000
CY2021Q3 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
396000
CY2020Q4 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
275000
chth Disposal Cost
DisposalCost
143000
CY2021Q3 chth Financing Coordination Fees
FinancingCoordinationFees
1500000
chth Financing Coordination Fees
FinancingCoordinationFees
1500000
CY2021Q3 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
3575000
CY2020Q3 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
4513000
CY2020Q4 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1505000
CY2021Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5962000
CY2020Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5399000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
16025000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
16436000
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1587000
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1780000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3900000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000
CY2021Q3 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
1600000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
4300000
CY2021Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
400000
CY2020Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-100000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-400000
CY2020Q3 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
500000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-500000
CY2021Q3 chth Number Of Promoted Interest Agreements
NumberOfPromotedInterestAgreements
2
CY2021Q3 chth Number Of Promoted Interest Agreements Met Established Performance Metrics
NumberOfPromotedInterestAgreementsMetEstablishedPerformanceMetrics
0

Files In Submission

Name View Source Status
0000950170-21-004315-index-headers.html Edgar Link pending
0000950170-21-004315-index.html Edgar Link pending
0000950170-21-004315.txt Edgar Link pending
0000950170-21-004315-xbrl.zip Edgar Link pending
chth-20210930.htm Edgar Link pending
chth-20210930.xsd Edgar Link pending
chth-20210930_cal.xml Edgar Link unprocessable
chth-20210930_def.xml Edgar Link unprocessable
chth-20210930_htm.xml Edgar Link completed
chth-20210930_lab.xml Edgar Link unprocessable
chth-20210930_pre.xml Edgar Link unprocessable
chth-ex31_1.htm Edgar Link pending
chth-ex31_2.htm Edgar Link pending
chth-ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img261523031_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending